Patent Yard Sign in
Canadian application, no grantCanada

A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"

CA 2403084 A1 · Owner: Biognostik Gesellschaft Fur Biomolekulare Diagnostik Mbh · Inventors: Bogdahn, Ulrich; Schlingensiepen, Reimar; Jachimczak, Piotr

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for stimulating immune cells and/or the immune system and/or , reducing invasion and/or metastasis of tumor cells by inhibiting expression and/or functional activity of "Melanoma Inhibitory Activity" MIA.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 10, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 10, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 10, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 10, 2001
GrantedNo grant recorded
Term endedMarch 10, 2021
Patent numberCA 2403084 A1
Classification (IPC)A61K38/17 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedMarch 10, 2001Term endedMarch 10, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.